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1. Introduction
Even though chronic gastritis was well established as a risk factor for the development of
several gastric pathologies, such as peptic ulceration, gastric carcinoma, and lymphoma, before
the discovery of Helicobacter pylori by Warren and Marshall in 1983 (Warren, 1983), the
development of chronic gastritis was thought to be due to a plethora of possible causes such
as stress, excessive alcohol consumption, ingestion of hot beverages and spicy food, among
others (Mobley et al., 2001). With the association of Helicobacter pylori as the cause of chronic
gastritis, the understanding of bacterial pathogenicity and the host response against the
bacterium take enormous importance to understand the pathophysiology of the infection.
It is estimated that almost half of the world’s population is infected with Helicobacter pylori and
although the majority of colonized individuals remain asymptomatic, the infection represents
the primary cause of chronic gastritis and it is a risk factor for the development of gastric cancer;
it was the first bacterium classified as a type 1 carcinogen by the IARC in 1994 (IARC, 1994).
Gastric cancer, despite its declining incidence rate, it remains as the fourth most common
cancer and the second cause of cancer-related death worldwide (Ferlay J, 2010) and epide‐
miological studies have determined that attributable risk for gastric cancer conferred by H.
pylori infection is approximately 75% (Peek & Blaser, 2002).
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The development of gastritis associated with the infection is a multifactorial process, where
the bacterium and host factors influence the pathogenesis of the disease. Colonization by H.
pylori causes chronic gastritis, that can remain asymptomatic, produces gastric epithelial
damage (Ricci et al., 2011). In the initial phase of infection, the bacteria penetrate through the
mucous layer to multiply in the proximity of epithelial cells. The gastric epithelium responds
to the infection by mucin depletion and cellular regenerative changes (Mobley et al., 2001); it
also occurs the infiltration of polymorphonuclear cells into surface epithelium and hypochlo‐
rhydria and a deficient ascorbic acid secretion are also observed (Sobala et al., 1993). Later,
bacterial components penetrate through the damaged epithelium and stimulates the produc‐
tion of IL-8 and IL-1 by macrophages, the activation and degranulation of mast cells and the
release of inflammatory mediators that increase vascular permeability and up-regulate the
expression of leukocyte adhesion molecules (Mobley et al., 2001). As the immune response
fails to eliminate the bacteria, it occurs a gradual accumulation of inflammatory cells, which
represents an active chronic phase of gastritis.
2. Helicobacter pylori virulence factors in gastritis and gastric cancer
Researchers have studied H. pylori’s virulence factors, to elucidate their role in the development
of gastritis and gastric cancer, the most studied are the pathogenicity island (cag-PAI) and its
effector, the cytotoxin associated protein (CagA) and the vacuolating cytotoxin (VacA).
However, there are other virulence factors (Figure 1), including the urease, lipopolysaccharide,
peptidoglycan, several adhesins, such as outer inflammatory protein (OipA), sialic acid-
binding adhesin (SabA), blood group antigen-binding adhesin (BabA/B), that contribute to the
damage in the gastric epithelium (Backert et al., 2010).
3. Urease
To colonize the stomach, H. pylori has to survive in the presence of acid produced in the
stomach. To counteract this acidic environment, H. pylori produces an important enzyme,
urease, which hydrolyses urea into NH3 and CO2. This enzyme has an essential role in the H.
pylori infection as observed in urease-defective bacteria mutants which cannot colonize the
stomach (Montecucco & Rappuoli, 2001). Urease causes damage to the epithelium through
the production of ammonia, that in conjunction with neutrophil metabolites (Megraud et al.,
1992), form carcinogenic agents that might participate in the development of gastric malig‐
nances (Suzuki et al., 1992). Ammonia is capable of cause different cell alterations, including
swelling of intracellular acidic compartments, alterations of vesicular membrane transport,
repression of protein synthesis and ATP production, and cell-cycle arrest (Montecucco &
Rappuoli, 2001). Urease might also help to the recruitment of neutrophils and monocytes in
the mucosa and to the production of proinflammatory cytokines (Harris et al., 1996).
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Figure 1. Helicobacter pylori virulence factors activities. Although CagA and VacA are the most studied virulence fac‐
tors, there are more bacterial proteins that promote damage to the host cells.
4. Lipopolysaccharides (LPS) and peptidoglycan
H. pylori LPS are essential components of the bacterial outer membrane that induces a low
immunological response in contrary to other bacteria (Moran, 1995). However, despite the low
immunological activity of LPS, H. pylori colonization is associated with an inflammatory
response, because H. pylori has the ability of activate mononuclear cells by LPS-independent
mechanisms as well as other bacterial surface molecules (Mai et al., 1991, Moran, 1998).
Another important component of the cell wall of H. pylori, peptidoglycan, interacts with the
intracellular pattern recognition receptor Nod1 (an intracellular sensor for peptidoglycan from
Gram-negative bacteria), this interaction leads to activation of NF-κB signaling, whit the
subsequent secretion of the inflammatory molecules IL-8 (Viala et al., 2004) and β-defensin-2
(Boughan et al., 2006). On the other hand, peptidoglycan translocation of H. pylori, leads to
enhanced PI3K-AKT signaling, which mediates protection from apoptosis and cell migration,
both phenotypes related to carcinogenesis (Nagy et al., 2009).
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5. Adhesins
Approximately 4% of the H. pylori genome is predicted to encode outer membrane proteins
(OMPs) many of which serve as adhesins (Wroblewski et al., 2010), epithelial adhesion
provides to H. pylori better access to epithelial surface and in this way contributes to deliver
bacterial toxins such as CagA (Yamaoka, 2010). Fucosylated ABO blood group antigens and
sialyl-Lewisx and sialyl-Lewisa antigens (sLex and sLea) have been identified as functional
receptors for H. pylori (Boren et al., 1993).
The outer membrane inflammatory protein (OipA), identified in 2000 (Yamaoka et al., 2000),
is involved in the attachment of H. pylori to gastric epithelial cells in vitro (Yamaoka, 2010).
OipA is also involved in up-regulation of matrix metalloproteinase 1 (MMP-1), in inhibition
of glycogen synthase kinase 3β (GSK-3β) and in β-catenin translocation to the nucleus, this
protein also induces an inflammatory response and actin rearrangement through phosphor‐
ylation signaling pathways (Wroblewski et al., 2010), although, most of these are also involved
in cag-PAI signaling alterations, suggesting that there might be some interaction between OipA
and cag-PAI, it is important to note that it has been found a correlation coefficient of 0.82
between the oipA and cagA positivity in some virulent strains (Yamaoka et al., 2002).
Blood group antigen binding adhesin (BabA), has been thought to be the primary protein
involved in adherence to the gastric mucosa (Boren et al., 1993). It is encoded by the babA2
gene (the babA1 although is present, is silent because of lack of an initiation codon (Mobley et
al., 2001) and binds to fucosylated Lewisb antigen. Some studies report that the presence of
babA2 is associated with duodenal ulcer and gastric cancer and found in conjunction with cagA
and vacA s1 allele, provides a greater risk of develop a severe gastric disease (Gerhard et al.,
1999).
Sialic  acid-binding  adhesin  (SabA)  is  responsible  of  H.  pylori  binding  to  syalylated  Lex
and Lea  in epithelial cells.  Infiltration of neutrophils into the gastric mucosa is a charac‐
teristic  feature  of  chronic  gastritis  caused  by  H.  pylori  and  SabA  binds  to  neutrophils
through  this  sialylated  carbohydrates  and  induces  oxidative  burst  in  these  cells,  which
has  a  consequence of  produce oxidative  damage in  gastric  epithelium.  It  has  been pro‐
posed  that  SabA-positive  status  is  associated  with  gastric  cancer,  intestinal  metaplasia,
and corpus atrophy and negatively associated with duodenal ulcer and neutrophil  infil‐
tration (Yamaoka, 2008).
6. Vacuolating cytotoxin (VacA)
VacA is a pore-forming cytotoxin identified in supernatants of H. pylori broth cultures that
cause aberrant vacuolation of cultured cells (Leunk et al., 1988). This cytotoxin is secreted from
the bacteria as a large 140-kilodalton polypeptide and latter trimmed at both ends to finally
deliver it in an active form to host cells, where it exerts its activity.
VacA induces multiple cellular activities, the best studied is the alteration on endosomal
maturation which consequently leads to vacuolation of epithelial cells, VacA is also capable
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of induce membrane-channel formation, cytochrome c release from mitochondria, and binding
to cell-membrane receptors activating a proinflammatory response (Amieva & El-Omar,
2008). VacA has the ability to cause leakage of ions and small molecules, by disrupting the
barrier function of tight junctions (Papini et al., 1998) and also inhibit T-cell activation and
proliferation (Gebert et al., 2003).
All strains of H. pylori contain the vacA gene, although, there is considerable genetic diversity
among them, and consequently the cytotoxicity activity of the toxin varies between strains
(Amieva & El-Omar, 2008). The diversity observed is attributed to variations in vacA gene
structure within the signal (s) region, the middle (m) region, and the intermediate (i) region
(Wroblewski et al., 2010).
The amino terminus contains the signal sequence that shows allelic variability and has been
classified into different types. Strains with s1 allele secrete an active toxin and are also highly
associated with ulcers and gastric cancer (Atherton et al., 1995), however, s1/s2 combination
or s2 genotypes are found in patients with gastric cancer (Lopez-Vidal et al., 2008). The middle
region of the gene also shows allelic variation, with m1 subtype having stronger vacuolating
activity and it is associated with an increased risk for development of gastric epithelial injury
and gastric cancer (Yamaoka, 2010).
The clinical isolates of H. pylori have been grouped into two broad families defined as type I
and type II on the basis of whether they have a functional pathogenicity island (cag-PAI), and
secrete an active vacuolating cytotoxin (VacA). Type I strains are positive for all these charac‐
teristics. In contrast, type II strains do not have a functional cag-PAI and possess the vacA gene
that encodes for non-toxic protein (Censini et al., 1996, Tomb et al., 1997).
7. Cytotoxin associated gen-Pathogenicity Island (cag-PAI)
Colonization of the human stomach by H. pylori virulent strains is associated with a signifi‐
cantly increased risk for the development of several gastric diseases, such as gastric cancer.
These highly virulent H. pylori strains harbor a (cytotoxin-associated genes) pathogenicity
island (cag-PAI) that encode proteins that are components of a type IV secretion system (T4SS)
apparatus and the CagA effector protein into host target cells (Castillo-Rojas et al., 2004). T4SS
translocates the bacterial oncoprotein CagA and peptidoglycan that induces proinflammatory
chemokine and cytokine secretion, including interleukin-8 (IL-8) in gastric epithelial cells
(Figueiredo et al., 2005). The hallmark of H. pylori virulent strains is the presence of cag-PAI
that induce of gastric mucosal inflammation, which is a risk factor for developing severe gastric
pathologies (Antonio-Rincon et al., 2011).
The presence of flanking direct repeated sequences 605 (IS605) in the cag-PAI have been
reported to cause rearrangements and partial or total deletions of it. This has generated H.
pylori strains with varying virulence, and consequently, the clinical outcome of the infection
(Censini et al., 1996).
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T4SSs are a large group of highly versatile secretion machineries in many Gram-negative
pathogenic bacteria that are evolutionarily related to bacterial conjugative systems (Fronzes
et al., 2009). Although the H. pylori cag-PAI has been evolutionarily related to others T4SSs
based on their common features like structural and sequence similarities, only a few cag PAI
proteins (also termed as HP o VirB/D) show clear sequence similarities to the prototypical
system of A. tumefaciens and other bacterial species.
A systematic mutagenesis study with isogenic mutants in each of the cag-PAI genes, reported
that 14 genes out of 27 of cag-PAI are essential for CagA translocation and induction of IL-8
secretion in gastric epithelial cells (Aguilar et al., 2001).
Twelve genes out of 27 of cag-PAI encoded proteins share sequence similarities with compo‐
nents of the prototypical T4SS system VirB/D4 of Agrobacterium tumefaciens, which contains 11
essential proteins of the secretion apparatus (VirB1–VirB11) encoded by the operon virB and
a coupling protein (VirD4) that mediates substrate recognition (Fronzes et al., 2009). The
majority of these proteins are conserved among the known T4SSs of other bacteria (Alvarez-
Martinez & Christie, 2009).
The prototypical (macromolecular complex) T4SS of A. tumefaciens, is among the best-studied
T4SS and is composed of two major structural complexes: the T-pilus and a membrane-
associated complex responsible for the translocation of substrates acrosss the inner and the
outer membrane (Fronzes et al., 2009, Alvarez-Martinez & Christie, 2009). The membrane-
associated complex includes the energetic components VirB4, VirB11 and VirD4, which are
conserved among the known T4SSs of other bacteria. These proteins contain Walker nucleotide
binding, and hydrolysis motifs and are known to energize T4SS for its function. The mem‐
brane-associated complex also includes the proteins VirB1, VirB3, VirB6, VirB7, VirB8, VirB9
and VirB10 that form the substrate translocation channel that spans both bacterial membranes.
VirB6, VirB8, and VirB10 are part of the subcomplex of proteins attached to the inner membrane
with domains spanning the periplasm, while VirB7 and VirB9 are part of the outer membrane
subcomplex. The T4SS-determined T-pilus is an extracellular appendage that is thought to
initiate cell–cell contact with plant target cells before the initiation of T-DNA transfer. This
structure includes the proteins VirB2 and VirB5 as major and minor components, respectively
(Backert et al., 2008).
H. pylori and A. tumefaciens share similarity in several components of their T4SSs and probably
function in a similar manner (Backert & Meyer, 2006). Nevertheless, the molecular mechanisms
responsible for assembly, activity and specific recognition of host target cells of these macro‐
molecular complexes remains unclear. It has been suggested that after the induction by cell
contact, H. pylori forms T4SS pili located at one bacterial pole for the injection of virulence
factors into target cells such as the oncoprotein CagA.
8. Cytotoxin-associated protein (CagA)
CagA protein is the only known effector protein translocated to the host cell by the T4SS
(Backert et al., 2010). It was firstly described as a very immunogenic protein in humans infected
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with cytotoxin-producing strains (Covacci et al., 1993). After that, its association with gastric
cancer and peptic ulcer was well established.
Recent reports suggest that CagA is able to down regulate the vacuolation effects of VacA on
host cells, and conversely, VacA is able to down regulates CagA activity (Oldani et al., 2009,
Tegtmeyer et al., 2009). Clinical isolates that contain the cag-PAI generally are babA, oipA and
vacA s1 positive, Yamaoka proposes that these virulence factors may interact with each other
with a certain biological significance; therefore, these factors interact synergistically with each
other to induce gastric diseases (Yamaoka, 2010).
CagA is encoded by the cagA gene, located at one end of the cag-PAI (Censini et al., 1996). One
copy per genome is present in most of the strains whose genome has been sequenced but strains
with two gene copies might exist, as revealed by the genome sequence of the Amerindian
strains H. pylori Shi470 and V225d, although functionality of both copies in these strains is
unknown (Kersulyte et al., Mane et al., 2010). It has been estimated that 60-95% of strains
worldwide carry the cagA gene, which is different between geographic regions (Hatakeyama,
2004). However, the complete cag-PAI is important for the translocation of this protein and the
completeness of the island may impact on the association of CagA presence and the outcome
of the disease.
Other main feature of CagA protein is its high variable size, which range from 120-145 kDa
(Covacci et al., 1993, Tummuru et al., 1993). This variation is due to the presence of polymor‐
phism at the carboxy-terminal region given by the presence of repeat sequences called EPIYA
motifs, which are present in a copy number varying from one to seven (Xia et al., 2009). Four
major types of EPIYA motifs (A, B, C, and D) have been described based on the specific amino
acid sequence that flanks the Glu-Pro-Ile-Tyr-Ala motif at both sides (Hatakeyama, 2004).
The EPIYA-repeat region of CagA is made of tandem alignment of the four distinct EPI‐
YA segments (A, B, C, D) in various combinations (Hatakeyama, 2011).  CagA molecules
containing  the  EPIYA-A,  EPIYA-B  and  EPIYA-C  segments  in  tandem  are  denoted  as
‘‘western type’’,  and are found in many H. pylori  isolates  from Europe,  North America,
and Australia.  On the other hand, CagA carrying EPIYA-A, EPIYA-B and EPIYA-D seg‐
ments are called “East Asian type” and have been isolated in East Asian countries such
as Japan, Korea and China (Furuta et al., 2011).
The EPIYA-C segment in "Western type" isolates can be present in up to five copies which
might be due to recombination mediated by a 16 amino acid sequence designated CagA
multimerization sequence that is present at both sides of EPIYA-C motif. The CagA multime‐
rization sequence is also present in EPIYA-D but only at one end, therefore cannot duplicate
by this mechanism (Furuta et al., 2011). Other implications of CagA multimerization sequence
in the bacterial pathogenicity will be discussed later in the text.
It has been proposed that EPIYA motifs of CagA act as ‘‘master keys’’ that can potentially be
tyrosine-phosphorylated by host kinases and are capable to interact with a wide range of
different host cell proteins (Backert et al., 2010). In the same way, the observation that the
EPIYA-region is unstructured and can adopt multiple conformations mimicking host sub‐
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strates of kinase families, thus manipulating eukaryotic cellular biochemistry during infection,
provides further support for this "master key" hypothesis (Nesic et al., 2010).
In contrast to the polymorphic C-terminal EPIYA region of CagA, N-terminal region is well
conserved among CagA proteins (Hatakeyama, 2011). The N-terminal CagA region is required
for the membrane association of CagA in polarized epithelial cells (Bagnoli et al., 2005) and is
important for its translocation into host cells (Murata-Kamiya et al., 2010), the first 200 amino
acids at the N-terminus of CagA form a membrane-binding domain in H. pylori, mediating
proper translocation of the CagA protein via the T4SS (Steininger et al., 2011).
9. CagA tridimensional structure and membrane localization
It has been shown that CagA targeting to the epithelial cell membrane is important for host
signaling (Higashi et al., 2002, Bagnoli et al., 2005, Higashi et al., 2005) and there is evidence
that membrane binding of CagA is important for its translocation into host cells (Murata-
Kamiya et al., 2010, Steininger et al., 2011).
Recently, it has been proposed that interaction of CagA with host cell proteins depends on the
localization of CagA into distinct compartments in host cells (Pelz et al., 2011). The model
proposed states that membrane localization is mediated by two membrane domains, one
composed by residues 1-200 (N-terminal domain) and the other from 200-1216 (C-terminal
domain), detailed description of the function of these domains are described in the Figure 2.
In addition, C-terminal domain is comprised of two regions that interact with each other and
are located in the membrane together when linked to N terminal domain, the first region is
from amino acids 200-800 containing phosphatidyl serine binding domain and the second from
800-1216 containing EPIYA and CagA multimerization motifs. The region from 800-1216 when
expressed alone localizes in cytosol and produces a strong alteration in cell morphology
(Steininger et al., 2011).
According with the above-mentioned model, CagA spatial conformation may play an im‐
portant  role  for  the  proper  translocation  and compartmentalization,  so  a  tridimentional
structure prediction of  CagA was made using I-TASSER, which has been ranked as the
best  method for  the automated protein structure  prediction in  the last  two community-
wide critical  assessment  of  protein  structure  prediction (CASP)  experiments  (Roy et  al.,
2010). The best predicted model for both East-Asia and Western type of CagA consists of
a sinuous super helical  structure in which N-terminal  region protrudes at  one side and
C-terminal region forms a loop (Figure 3).  These predicted structural models agree with
the  model  proposed of  Steininger  et  al.,  in  which  amino acids  200-1216  forms two do‐
mains that interact with each other (Steininger et al.,  2011).  According to the results ob‐
tained  with  I-TASSER  the  most  similar  structure  available  in  the  PDB  database
(www.rcsb.org/pdb/home/home.do)  is  from  Cand1  protein,  however  the  only  function
similarity shared with CagA is the capacity of protein binding.
Interestingly, it is also proposed that N-terminal membrane-binding domain functions as an
inhibitory domain of the C-terminal region effects, and that region from 800-1216 when ex‐
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pressed alone induces the highest percentage of epithelial cell elongation (Pelz et al., 2011).
Also it has been proposed that CagA is cleaved by proteases in human cells yielding two
fragments of about 100-105 kDa and 35-40 kDa (Moese et al., 2001), the last would corre‐
spond to the region from amino acid 800-1216. This leads to the question if some structural
variants of CagA are better cleaved inside the host cell so that can not be totally inhibited by
the N-terminal membrane-binding domain, but this requires investigation.
Figure 2. CagA structure in schematic representation. The most common variants of western and East Asian type are
depicted. CagA possess at least two membrane-binding domains (Steininger et al., 2011), which are marked with quo‐
tation. Main known functions of certain regions are mentioned.
10. Phosphorylation-dependent cell signaling of CagA
Phosphorylation of CagA deregulates several signaling pathways leading to modification in
host cell shape and adhesion, contributing to the transformation of cells (Hatakeyama, 2011,
Jones et al., 2010). All of the EPIYA motifs in the four distinct EPIYA segments serve as tyrosine
phosphorylation sites of CagA in host cells (Hatakeyama, 2011). Enzymes that can phosphor‐
ylate CagA in vitro and during infection in vivo are members of the Src and Abl families, which
have been, recognized as oncogenic tyrosine kinases (Selbach et al., 2002, Stein et al., 2002,
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Poppe et al., 2007, Tammer et al., 2007). The phosphorylation is a hierarchic regulated process
in which c-Src phosphorylates EPIYA-C or EPIYA-D early in infection, while c-Abl phosphor‐
ylates either EPIYA-A, EPIYA-B, EPIYA-C, or EPIYA-D later in infection but only 2 EPIYA
sites can be simultaneously phosphorylated per CagA molecule (Mueller et al., 2012). Fur‐
thermore, simultaneous phosphorylation of EPIYA-AC or EPIYA-BD confers strongest
elongation phenotype in an AGS cellular model, even in a single CagA protein with both of
the phosphorylatable EPIYA motifs (preferably EPIYA-AC), or in 2 independent CagA
proteins, each with a single phosphorylatable EPIYA motif, which may form dimers to trigger
this response (Mueller et al., 2012).
Figure 3. Tridimensional structure of CagA. The model was predicted using I-TASSER, image was obtained using UCSF
CHIMERA software (Pettersen et al., 2004).
Once tyrosine phosphorylated, EPIYA-C or -D can bind to SHP-2 phosphatase (Hatakeyama,
2011) and activates the phosphatase activity of Shp2 producing an extremely elongated cell
shape known as the hummingbird phenotype and altered cell motility (Backert et al., 2010,
Higashi et al., 2004, Tsutsumi et al., 2006). SHP2 is required for full activation of the
MAPK/ERK pathway, which conveys a potent mitogenic signal (Matozaki et al., 2009) and for
direct dephosphorylation and inactivation of focal adhesion kinase, FAK, that deregulates
integrin signaling (Tsutsumi et al., 2006).
Carrying the type EPIYA-D or multiple EPIYA-C repeats is associated with increased SHP-2
phosphatase activity induced by CagA, increasing the risk of precancerous and cancer lesions.
This is because East-specific D segment shows higher binding affinity to SHP2 than the West-
specific C segment but the C-type motif is variable in copy number and sequence, which can
provide more sites for SHP2 binding.
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On the  other  hand,  phosphorylated EPIYA-A and EPIYA-B have been shown ability  to
bind to Csk (Tsutsumi et  al.,  2003).  Interaction of  CagA with Csk stimulates  the kinase
activity of Csk, which in turn inhibits Src in a negative feedback loop that constrains the
phosphorylation-dependent CagA activity below a certain threshold to ensure long-term
colonization  of  H.  pylori  in  the  stomach  without  causing  fatal  damages  (Hatakeyama,
2011). In addition, phosphorylated EPIYA-B can interact with phosphatidylinositol 3-kin‐
ase  (PI3K)  that  regulates  diverse  cellular  functions  including  proliferation  and  survival
via AKT pathway (Nagy et al., 2009).
11. Phosphorylation-independent cell signaling of CagA
Recent studies have shown that not all cellular interactions exerted by CagA depend on its
tyrosine phosphorylation so far more than 13 cellular interaction partners of non-phosphory‐
lated CagA have been identified (Backert et al., 2010, Tegtmeyer et al., 2009, Mimuro et al.,
2002). It has been shown that these interactions exert effects such as pro-inflammatory and
mitogenic responses, disruption of cell-to-cell junctions or loss of cell polarity.
The first cellular interaction partner described of non-phosphorylated CagA was the adapter
protein Gbr2 (Mimuro et al., 2002). Recently, it was reported that Gbr2 is the only host factor
that interacts with both phosphorylated and non-phosphorylated EPIYA motifs (Selbach et al.,
2009). Non-phosphorylated CagA was shown to interact with Gbr2 both in vitro and in vivo,
which provides a mechanism by which Gbr2-associated SOS (son of sevenless) is recruited to
the plasma membrane, this complex (CagA-Gbr2-SOS) can promote Ras-GTP formation,
leading to cell scattering by stimulation of the MAPK/ERK signaling pathway as well as
activation of nuclear transcription factors involved in cell proliferation and expression of the
anti-apoptotic myeloid cell leukemia sequence-1 protein (Mimuro et al., 2007).
On the other hand, Chang YJ, et al., 2006, reported that cagA-positive H. pylori strains affect
the cell cycle during infection by stimulating cyclin D1 expression, G1-S phase progression
and host cell survival, suggesting the presence of distinct functional domains within CagA
that play essential roles in protein targeting and alteration of host-cell transcription signaling
pathways (Chang et al., 2006).
Yokoyama et al., 2005, found that CagA can stimulate the calcium-dependent serine/threonine
phosphatase calcineurin in gastric epithelial cells, inducing translocation of the nuclear factor
of activated T cells (NFAT) from the cytoplasm to the nucleus, where activates NFAT-
dependent genes (Yokoyama et al., 2005). It is possible that the reported CagA-PLC interaction
triggers Ca2+ mobilization and subsequent activation of calcineurin.
One of the NFAT-dependent genes activated by CagA in gastric epithelial cells is p21Cip1, a
cyclin-dependent kinase inhibitor. Accordingly, although CagA activates a growth-promoting
signal via the SHP-2-MAP kinase pathway or the Grb2-Ras-MAP kinase pathway, it simulta‐
neously inhibits cell proliferation through NFAT-dependent p21Cip1 induction. Intriguingly,
the H. pylori-vacuolating toxin vacA counteracts the activity of CagA to stimulate NFAT. Thus,
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VacA has a role in determining the magnitude of NFAT deregulation in gastric epithelial cells
expressing CagA. Such a functional interplay between CagA and VacA has already been
suggested from the observation that secretion of VacA protein is associated with the presence
of CagA despite the presence of vacA gene in all H. pylori strains (Yokoyama et al., 2005).
The CagA multimerization sequence mediates a stable binding with SHP-2 protein poten‐
tiating CagA virulence and is also responsible of the phosphorylation-independent activi‐
ty  of  CagA (Ren et  al.,  2006,  Nagase et  al.,  2011).  Furthermore,  it  has  been shown that
CagA  binds  and  inhibits  the  polarity-regulating  kinase  partitioning-defective  1  (PAR1)/
microtubule  affinity-regulating  kinase  (MARK)  through CagA multimerization  sequence
(Nagase et  al.,  2011).  Kurashima et al.,  showed that CagA multimerization sequence de‐
stabilizes  the  E-cadherin/beta-catenin  complex  to  trigger  aberrant  activation of  the  beta-
catenin  signal  that  underlies  intestinal  metaplasia  (Kurashima  et  al.,  2008).  Recently,  it
was shown that  the diversity in the structure and number of  CagA multimerization se‐
quences influence the strength of pathological activities of individual CagA with its cellu‐
lar  targets  (PAR1b  and  SHP-2),  emphasising  its  importance  as  a  determinant  of  the
degree of virulence of CagA (Lu et al., 2008) for development of gastric cancer.
A recent  study shows that  CagA can also  interact  with runt-related transcription factor
gene 3 (RUNX3, a tumor suppressor that is frequently inactivated in gastric cancer) by a
novel identified WW domain in the amino-terminal region of CagA (Tsang et al.,  2010).
In particular, CagA induces the ubiquitination and degradation of RUNX3, thereby extin‐
guishing its ability to inhibit the transcriptional activation of RUNX3; currently, function‐
al inactivation of RUNX3 can be caused by mutation, epigenetic gene silencing (promoter
methylation) or cytoplasmic protein mislocalization (Ito,  2011).  Recent evidence shows a
strong association between methylation of the RUNX3 promoter and gastric cancer (Fan
et al., 2011, Li et al., 2011). Recently, Lin et al., found that loss of RUNX3 in gastric can‐
cer  prevents  G1 phase arrest  and promotes  tumorigenesis  through Akt1/ß-catenin/cyclin
D1 signaling pathway (Lin et al., 2012).
A consequence of non-phosphorylated CagA interactions in polarized epithelial cells is the
disruption of cell junctions. In particular, tight and adherence junctions are essential for the
integrity of the gastric epithelium (Wessler & Backert, 2008). CagA interferes with these
intercellular junctions via several pathways. 1) Injected CagA associates with the epithelial
tight-junction scaffolding protein, zone occludens-1 (ZO-1), and the transmembrane protein,
junction adhesion molecule (JAM2), causing an ectopic assembly of tight-junction components
at sites of bacterial attachment (Amieva & El-Omar, 2008), leading to alterations of cell polarity.
2) Non-phosphorylated CagA can interact with the transmembrane cell-cell junction protein
E-cadherin (Hatakeyama, 2008). Subsequently, it was found that CagA forms a complex with
c-Met recruiting E-cadherin and the Armadillo-domain protein, catenin delta, indicating that
the interaction between CagA and E-cadherin is not direct (Oliveira et al., 2009). Baek et al., in
2007, reported that the interaction of alpha-Pix (PAK-interactive exchange factor) with CagA
activates PAK1, ERK and NF-κB, which induces IL-8 expression (Baek et al., 2007, Lim et al.,
2009); beta 1 integrin (integrin ß1) is another CagA-independent signaling that promotes cell
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motility (Snider et al., 2008), although the functional importance of this interaction needs to be
investigated.
12. Concluding remarks
Studies host interactions with H. pylori virulence factors, such as CagA and the T4SS, have
provided us many fundamental insights into the processes leading to H. pylori pathogenesis.
The current hypothesis implies a model with translocated CagA as an "eukaryotic" signaling
mimetic molecule either present in a large multiprotein complex or simultaneously in sepa‐
rated locations whitin infected target cells, which may have an important impact on the
multistep pathogenesis of H. pylori. In the future, it will be important to search for additional
injected proteins because it is rather unlikely that cag-PAI acquisition during evolution was
intended to inject few effectors like CagA and peptidoglycan. Future studies are required to
uncover the complex mechanisms that explain how H. pylori interacts whit host cells at the
molecular level to accomplish its persistence through host life.
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